# A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis

> **NCT01906658** · PHASE2 · COMPLETED · sponsor: **Mallinckrodt** · enrollment: 43 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Repository corticotropin injection

## Key facts

- **NCT ID:** NCT01906658
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-11
- **Final completion:** 2014-12
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2017-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01906658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01906658, "A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01906658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*